Compare Stocks

2 / 10
Try these comparisons:

Stock Comparison

APXT vs MS

Revenue, margins, valuation, and 5-year total return — side by side.

Live fundamentals10-year financials5-year price chart
APXT
Apex Technology Acquisition Corporation

Shell Companies

Financial ServicesNASDAQ • US
Market Cap$1.94B
5Y Perf.+2.1%
MS
Morgan Stanley

Financial - Capital Markets

Financial ServicesNYSE • US
Market Cap$302.59B
5Y Perf.+330.3%

APXT vs MS — Key Financials

Market cap, revenue, margins, and valuation side-by-side.

Company Snapshot
APXT logoAPXT
MS logoMS
IndustryShell CompaniesFinancial - Capital Markets
Market Cap$1.94B$302.59B
Revenue (TTM)$330M$103.14B
Net Income (TTM)$-57M$16.18B
Gross Margin75.0%55.6%
Operating Margin2.2%17.1%
Forward P/E16.0x
Total Debt$10M$360.49B
Cash & Equiv.$291M$75.74B

APXT vs MSLong-Term Stock Performance

Price return indexed to 100 at period start. Dividends excluded.

APXT
MS
StockMay 20May 26Return
Apex Technology Acq… (APXT)100102.1+2.1%
Morgan Stanley (MS)100430.3+330.3%

Price return only. Dividends and distributions are not included.

Quick Verdict: APXT vs MS

Each card shows where this stock fits in a portfolio — not just who wins on paper.

Bottom line: MS leads in 6 of 7 categories, making it the strongest pick for growth and revenue expansion and valuation and capital efficiency. Apex Technology Acquisition Corporation is the stronger pick specifically for capital preservation and lower volatility. As sector peers, any of these can serve as alternatives in the same allocation.
APXT
Apex Technology Acquisition Corporation
The Banking Pick

APXT is the clearest fit if your priority is income & stability and sleep-well-at-night.

  • beta 0.02
  • Lower volatility, beta 0.02, Low D/E 3.6%, current ratio 1.77x
  • Beta 0.02, current ratio 1.77x
Best for: income & stability and sleep-well-at-night
MS
Morgan Stanley
The Banking Pick

MS carries the broadest edge in this set and is the clearest fit for growth exposure and long-term compounding.

  • Rev growth 16.8%, EPS growth 53.5%
  • 7.3% 10Y total return vs APXT's 2.2%
  • 16.8% NII/revenue growth vs APXT's -198.1%
Best for: growth exposure and long-term compounding
See the full category breakdown
CategoryWinnerWhy
GrowthMS logoMS16.8% NII/revenue growth vs APXT's -198.1%
ValueMS logoMSBetter valuation composite
Quality / MarginsMS logoMSEfficiency ratio 0.4% vs APXT's 0.7% (lower = leaner)
Stability / SafetyAPXT logoAPXTBeta 0.02 vs MS's 1.37, lower leverage
DividendsMS logoMS2.0% yield; 11-year raise streak; the other pay no meaningful dividend
Momentum (1Y)MS logoMS+63.0% vs APXT's +0.8%
Efficiency (ROA)MS logoMSEfficiency ratio 0.4% vs APXT's 0.7%

APXT vs MS — Revenue Breakdown by Segment

How each company's revenue is distributed across its business units

APXTApex Technology Acquisition Corporation
FY 2024
SaaS
76.1%$319M
Termed License and Support
10.7%$45M
Service
10.5%$44M
Maintenance
2.7%$11M
MSMorgan Stanley
FY 2024
Wealth Management Segment
45.6%$28.4B
Institutional Securities Segment
45.0%$28.1B
Investment Management Segment
9.4%$5.9B

APXT vs MS — Financial Metrics

Side-by-side numbers across 2 stocks — who leads on profitability, valuation, growth, and risk.

BEST OVERALLAPXTLAGGINGMS

Income & Cash Flow (Last 12 Months)

APXT leads this category, winning 3 of 5 comparable metrics.

MS is the larger business by revenue, generating $103.1B annually — 312.1x APXT's $330M. MS is the more profitable business, keeping 13.0% of every revenue dollar as net income compared to APXT's -8.8%.

MetricAPXT logoAPXTApex Technology A…MS logoMSMorgan Stanley
RevenueTrailing 12 months$330M$103.1B
EBITDAEarnings before interest/tax$9M$26.3B
Net IncomeAfter-tax profit-$57M$16.2B
Free Cash FlowCash after capex$139M-$6.7B
Gross MarginGross profit ÷ Revenue+75.0%+55.6%
Operating MarginEBIT ÷ Revenue+2.2%+17.1%
Net MarginNet income ÷ Revenue-8.8%+13.0%
FCF MarginFCF ÷ Revenue+26.0%-2.0%
Rev. Growth (YoY)Latest quarter vs prior year
EPS Growth (YoY)Latest quarter vs prior year+5.0%+48.9%
APXT leads this category, winning 3 of 5 comparable metrics.

Valuation Metrics

MS leads this category, winning 3 of 4 comparable metrics.

On an enterprise value basis, MS's 25.8x EV/EBITDA is more attractive than APXT's 231.6x.

MetricAPXT logoAPXTApex Technology A…MS logoMSMorgan Stanley
Market CapShares × price$1.9B$302.6B
Enterprise ValueMkt cap + debt − cash$1.7B$587.3B
Trailing P/EPrice ÷ TTM EPS-62.50x23.92x
Forward P/EPrice ÷ next-FY EPS est.16.01x
PEG RatioP/E ÷ EPS growth rate2.69x
EV / EBITDAEnterprise value multiple231.63x25.81x
Price / SalesMarket cap ÷ Revenue5.87x2.93x
Price / BookPrice ÷ Book value/share6.74x2.91x
Price / FCFMarket cap ÷ FCF22.61x
MS leads this category, winning 3 of 4 comparable metrics.

Profitability & Efficiency

APXT leads this category, winning 5 of 9 comparable metrics.

MS delivers a 14.6% return on equity — every $100 of shareholder capital generates $15 in annual profit, vs $-12 for APXT. APXT carries lower financial leverage with a 0.04x debt-to-equity ratio, signaling a more conservative balance sheet compared to MS's 3.42x. On the Piotroski fundamental quality scale (0–9), APXT scores 6/9 vs MS's 5/9, reflecting solid financial health.

MetricAPXT logoAPXTApex Technology A…MS logoMSMorgan Stanley
ROE (TTM)Return on equity-12.2%+14.6%
ROA (TTM)Return on assets-7.7%+1.2%
ROICReturn on invested capital+1.7%+2.9%
ROCEReturn on capital employed+2.2%+3.8%
Piotroski ScoreFundamental quality 0–965
Debt / EquityFinancial leverage0.04x3.42x
Net DebtTotal debt minus cash-$281M$284.7B
Cash & Equiv.Liquid assets$291M$75.7B
Total DebtShort + long-term debt$10M$360.5B
Interest CoverageEBIT ÷ Interest expense0.65x0.44x
APXT leads this category, winning 5 of 9 comparable metrics.

Total Returns (Dividends Reinvested)

MS leads this category, winning 6 of 6 comparable metrics.

A $10,000 investment in MS five years ago would be worth $23,624 today (with dividends reinvested), compared to $9,852 for APXT. Over the past 12 months, MS leads with a +63.0% total return vs APXT's +0.8%. The 3-year compound annual growth rate (CAGR) favors MS at 33.6% vs APXT's 0.3% — a key indicator of consistent wealth creation.

MetricAPXT logoAPXTApex Technology A…MS logoMSMorgan Stanley
YTD ReturnYear-to-date+1.1%+5.7%
1-Year ReturnPast 12 months+0.8%+63.0%
3-Year ReturnCumulative with dividends+0.8%+138.4%
5-Year ReturnCumulative with dividends-1.5%+136.2%
10-Year ReturnCumulative with dividends+2.2%+732.3%
CAGR (3Y)Annualised 3-year return+0.3%+33.6%
MS leads this category, winning 6 of 6 comparable metrics.

Risk & Volatility

APXT leads this category, winning 2 of 2 comparable metrics.

APXT is the less volatile stock with a 0.02 beta — it tends to amplify market swings less than MS's 1.37 beta. A beta below 1.0 means the stock typically moves less than the S&P 500.

MetricAPXT logoAPXTApex Technology A…MS logoMSMorgan Stanley
Beta (5Y)Sensitivity to S&P 5000.02x1.37x
52-Week HighHighest price in past year$10.01$194.83
52-Week LowLowest price in past year$9.87$118.20
% of 52W HighCurrent price vs 52-week peak+100.0%+97.6%
RSI (14)Momentum oscillator 0–10054.266.0
Avg Volume (50D)Average daily shares traded52K5.4M
APXT leads this category, winning 2 of 2 comparable metrics.

Analyst Outlook

Insufficient data to determine a leader in this category.

MS is the only dividend payer here at 2.00% yield — a key consideration for income-focused portfolios.

MetricAPXT logoAPXTApex Technology A…MS logoMSMorgan Stanley
Analyst RatingConsensus buy/hold/sellBuy
Price TargetConsensus 12-month target$205.75
# AnalystsCovering analysts52
Dividend YieldAnnual dividend ÷ price+2.0%
Dividend StreakConsecutive years of raises11
Dividend / ShareAnnual DPS$3.81
Buyback YieldShare repurchases ÷ mkt cap+1.7%+1.4%
Insufficient data to determine a leader in this category.
Key Takeaway

APXT leads in 3 of 6 categories (Income & Cash Flow, Profitability & Efficiency). MS leads in 2 (Valuation Metrics, Total Returns).

Best OverallApex Technology Acquisition… (APXT)Leads 3 of 6 categories
Loading custom metrics...

APXT vs MS: Frequently Asked Questions

8 questions · data-driven answers · updated daily

01

Is APXT or MS a better buy right now?

Morgan Stanley (MS) offers the better valuation at 23.

9x trailing P/E (16. 0x forward), making it the more compelling value choice. Analysts rate Morgan Stanley (MS) a "Buy" — based on 52 analyst ratings — the highest consensus in this comparison. The "better buy" depends entirely on your goals: growth investors should weight revenue trajectory, value investors should weight P/E and PEG, and income investors should weight dividend yield and streak.

02

Which is the better long-term investment — APXT or MS?

Over the past 5 years, Morgan Stanley (MS) delivered a total return of +136.

2%, compared to -1. 5% for Apex Technology Acquisition Corporation (APXT). Over 10 years, the gap is even starker: MS returned +732. 3% versus APXT's +2. 2%. Past returns do not guarantee future results, and the stock with the higher historical return may already have its best growth priced in.

03

Which is safer — APXT or MS?

By beta (market sensitivity over 5 years), Apex Technology Acquisition Corporation (APXT) is the lower-risk stock at 0.

02β versus Morgan Stanley's 1. 37β — meaning MS is approximately 8103% more volatile than APXT relative to the S&P 500. On balance sheet safety, Apex Technology Acquisition Corporation (APXT) carries a lower debt/equity ratio of 4% versus 3% for Morgan Stanley — giving it more financial flexibility in a downturn.

04

Which is growing faster — APXT or MS?

On earnings-per-share growth, the picture is similar: Morgan Stanley grew EPS 53.

5% year-over-year, compared to -67. 7% for Apex Technology Acquisition Corporation. Higher growth typically commands a higher valuation multiple — check whether the premium P/E or P/S is justified by the growth rate using the PEG ratio.

05

Which has better profit margins — APXT or MS?

Morgan Stanley (MS) is the more profitable company, earning 13.

0% net margin versus -8. 8% for Apex Technology Acquisition Corporation — meaning it keeps 13. 0% of every revenue dollar as bottom-line profit. Operating margin tells a similar story: MS leads at 17. 1% versus 2. 2% for APXT. At the gross margin level — before operating expenses — APXT leads at 75. 0%, reflecting greater pricing power or product mix advantage. Stronger margins indicate durable pricing power, lower cost of revenue, or higher mix of software/services. They are one of the clearest signs of business quality.

06

Which pays a better dividend — APXT or MS?

In this comparison, MS (2.

0% yield) pays a dividend. APXT does not pay a meaningful dividend and should not be held primarily for income.

07

Is APXT or MS better for a retirement portfolio?

For long-horizon retirement investors, Apex Technology Acquisition Corporation (APXT) is the stronger choice — it scores higher on the combination of lower volatility, dividend reliability, and long-term compounding (low volatility (β 0.

02)). Both have compounded well over 10 years (APXT: +2. 2%, MS: +732. 3%), confirming both are viable long-term holds — but the lower-volatility option typically results in less emotional selling during corrections. Retirement portfolios generally favour predictability over maximum returns. Consult a financial advisor before making allocation decisions.

08

What are the main differences between APXT and MS?

Both stocks operate in the Financial Services sector, making this a peer-level intra-sector comparison — the same macro tailwinds and headwinds will affect both.

In terms of investment character: APXT is a small-cap quality compounder stock; MS is a large-cap high-growth stock. MS pays a dividend while APXT does not, making them suitable for different income and tax situations. These fundamental differences mean investors should not choose between them on a single metric — the "better stock" depends entirely on which of these characteristics aligns with your investment strategy.

Find Stocks Like These

Explore pre-built screens for each stock's profile, or build a custom screen to find stocks that outperform both.

Stocks Like

APXT

Quality Business

  • Sector: Financial Services
  • Market Cap > $100B
  • Gross Margin > 45%
Run This Screen
Stocks Like

MS

High-Growth Compounder

  • Sector: Financial Services
  • Market Cap > $100B
  • Revenue Growth > 8%
  • Net Margin > 7%
Run This Screen

You Might Also Compare

Based on how these companies actually compete and overlap — not just which sector they're filed under.